Major Milestone!

Great News!

FDA has accepted and filed Nanoscope Therapeutics' BLA ( Biologics License Application) for MCO-010 (MOGENRY).

“FDA acceptance and filing of our BLA for MOGENRY is a crucial milestone that brings us a critical step closer to offering a one-time, in-office treatment option to the retinitis pigmentosa community with severe vision loss, who have no approved therapy today,” said Sulagna Bhattacharya, Chief Executive Officer of Nanoscope Therapeutics. “

Thank you all for your signatures and support. Please continue sharing this petition as we urge FDA for expedited approval.